WO1993023164A1 - Separation method - Google Patents

Separation method Download PDF

Info

Publication number
WO1993023164A1
WO1993023164A1 PCT/DK1993/000159 DK9300159W WO9323164A1 WO 1993023164 A1 WO1993023164 A1 WO 1993023164A1 DK 9300159 W DK9300159 W DK 9300159W WO 9323164 A1 WO9323164 A1 WO 9323164A1
Authority
WO
WIPO (PCT)
Prior art keywords
catalyst
acid
reaction mixture
solid
reaction
Prior art date
Application number
PCT/DK1993/000159
Other languages
English (en)
French (fr)
Inventor
Svend Gunnar Kaasgaard
Camilla Helene Ulrich
Kim Clausen
Thomas Lisbjerg Jensen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Priority to BR9306349A priority Critical patent/BR9306349A/pt
Priority to JP5519788A priority patent/JPH07507959A/ja
Priority to SK1342-94A priority patent/SK134294A3/sk
Priority to EP93909823A priority patent/EP0640014A1/de
Publication of WO1993023164A1 publication Critical patent/WO1993023164A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J38/00Regeneration or reactivation of catalysts, in general
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J37/00Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
    • B01J37/009Preparation by separation, e.g. by filtration, decantation, screening

Definitions

  • the present invention relates to a method of separating a particulate solid catalyst from a chemical reac- tion mixture which further comprises at least one other solid component, either during the reaction or after the reaction.
  • Separation of a precipitate from a liquid is a well known process which can be carried out by decantation, filtration or centrifugation.
  • a reaction mixture contains two or more different solid components
  • solid components can be separated from each other by mechanical processes like floatation.
  • Other methods are physicochemical methods like extraction or partition, which utilize a difference in solubility of the components e.g. in water, in aqueous acid, in aqueous base or in organic solvents.
  • a pre ⁇ requisite of the applicability of these methods is that con ⁇ ditions can be found under which the components to be separ ⁇ ated are stable.
  • the price of the catalyst is often a very important parameter in the overall economy of the process. Therefore, it is an advantage of major importance if the catalyst can be reused without significant loss of catalytic activity.
  • the catalyst is present in a reaction mixture together with another solid component which is either formed during the reaction, such as a by-product or the desired product, or present during the whole process, e.g. a solid starting material added in excess, the isolation and reuse of the catalyst is hampered.
  • the catalyst can sometimes be iso ⁇ lated by extracting the other soli (s) with organic solvents and/or with acids or bases which will dissolve the soli (s) except for the catalyst.
  • activity of catalysts including enzymes, is very sensitive to the presence of so- called catalyst poisons.
  • Catalyst poisons exert their activi ⁇ ty e.g. by binding very strongly to the catalyst or by de- composing it.
  • strong acids and bases often have an adverse effect on the activity of catalysts and particularly enzymes generally suffer irreversible damage on exposure to high concentrations of acids or bases.
  • This imposes certain limitations on the use of acids and bases in the work up of reaction mixtures from enzymatic reactions when the enzyme is to be recycled without significant loss of activity.
  • Other limitations on the work up conditions may of course be im ⁇ posed by the nature of the desired product which may itself be a labile compound.
  • the prior art does not indicate a satisfactory solution to the separation problems outlined above.
  • the catalyst can, according to the present invention, be separated almost quantitatively by sieving or filtering the reaction -mixture after the reaction is considered to be finished or, optionally, in a continuous way.
  • catalyst particles of a well defined particle size range are used and the other solid componen (s) of the reaction mixture has (have) a particle size smaller than the lower limit of the apparent particle size range of the catalyst.
  • the separation of the catalyst is then carried out by letting the slurry which con ⁇ stitutes the reaction mixture pass through a sieve or a filter which will retain the catalyst particles and let the remainder of the mixture pass through. This can be done either in a batchwise or in a continuous way.
  • the separation of the solid components may be facilitated if the filter plate or sieve is vibrated during the separation or if the slurry on the filter plate is stirred. After the catalyst has been separated the remainder of the reaction mixture can be filtered on a filter which will retain the remaining solid component(s) .
  • the relative amounts of the desired product found in the filter cake and in the filtrate depends on the solubility of the desired product in the reaction medium.
  • the filtrate and the filter cake can be worked up separately, some components optionally being recirculated in the process together with the catalyst.
  • the present inven ⁇ tion relates to a method of separating a particulate solid catalyst from a reaction mixture which further comprises at least one other particulate solid component and a liquid by giving one of the particulate solid components an apparent particle size which is outside the apparent particle size range of the other solid component(s) whereupon the reaction mixture is filtered or centrifuged using equipment which will retain the component(s) having the larger particles and let the remainder of the mixture pass through.
  • the solid componen (s) to be separated from the catalyst has (have) an apparent particle size smaller than the lower limit of the apparent particle size range of the catalyst.
  • the ratio between the apparent diameter of the larger particles and the apparent diameter of the smaller particles to be separated is at least 2.
  • the apparent particle diameter of the catalyst is in the range of from 25 to 10,000 ⁇ m, preferably from 50 to 750 ⁇ m, more preferred from 50 to 300 ⁇ m.
  • the solid catalyst is an immobilized enzyme. In a further preferred embodiment of the inven ⁇ tion the solid catalyst is an immobilized protease.
  • the solid catalyst is an immobilized metalloprotease.
  • the solid catalyst is an immobilized serine protease.
  • the solid catalyst is immobilized thermolysin.
  • the solid catalyst is an immobilized amidase. In a further preferred embodiment of the inven ⁇ tion the solid catalyst is an immobilized esterase. In a further preferred embodiment of the inven ⁇ tion the solid catalyst is an immobilized acylase.
  • the solid catalyst is an immobilized enzyme which is able to deacylate the 6-amino group of penicillin G.
  • the solid catalyst is an immobilized enzyme which is able to deacylate the 6-amino group of ampicillin.
  • the immobilized enzyme is a penicillin G acylase.
  • the immobilized enzyme is an ampicillin hydrolase.
  • the solid catalyst is an immobilized whole cell prepara- tion.
  • the solid catalyst is an immobilized cell homogenate preparation.
  • a solid product produced in a process in which the starting material(s) is (are) fully dissolved in the reaction mixture is separated continuously from the catalyst during the reaction by leading the filtrate from the filter which retains the catalyst only to a filter which retains the solid product synthesized and recirculating the filtrate from this filter to the catalyst.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of a ⁇ -lactam antibiotic nucleus with the acid corresponding to the side chain or a derivative of this acid from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 6-amino group in 6-amino- penicillanic acid from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 7-amino- cephalosporanic acid from the remainder of the reaction mix ⁇ ture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 7-amino-7- methoxycephalosporanic acid from the remainder of the reac ⁇ tion mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 7-amino-3- methoxy-3-cephem-4-carboxylic acid from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 7-amino- desacetoxycephalosporanic acid from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 3-chloro-7— amino-3-cephem-4-carboxylic acid from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 7-amino-3-
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of the 7-amino group in 7-amino-3-
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with D-phenylglycine as the acylating agent from the re- mainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with a derivative of D-phenylglycine as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a ⁇ -lactam antibiotic nucleus with D-phenylglycine amide as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a ⁇ -lactam antibiotic nucleus with D-phenylglycine methyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with D-phenylglycine ethyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a ⁇ -lactam antibiotic nucleus with D-phenylglycine propyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /?-lactam antibiotic nucleus with D-phenylglycine isopropyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a 3-lactam antibiotic nucleus with D-4-hydroxyphenylglycine as the acylating agent from the remainder of the reaction mixture. In a further preferred embodiment, the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with a derivative of D-4-hydroxyphenylglycine as the acylat- ing agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with D-4-hydroxyphenylglycine amide as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with D-4-hydroxyphenylglycine methyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with D-4-hydroxyphenylglycine ethyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a ⁇ -lactam antibiotic nucleus with D-4-hydroxyphenylglycine propyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with D-4-hydroxyphenylglycine isopropyl ester as the acylat- ing agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a 0-lactam antibiotic nucleus with 2-thiopheneacetic acid as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a 3-lactam antibiotic nucleus with a derivative of 2-thiopheneacetic acid as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a 0-lactam antibiotic nucleus with 2-thiopheneacetic acid amide as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a 3-lactam antibiotic nucleus with 2-thiopheneacetic acid methyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with 2-thiopheneacetic acid ethyl ester as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with 3-thiophenemalonic acid as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the acylation of a /3-lactam antibiotic nucleus with a derivative of 3-thiophenemalonic acid as the acylating agent from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of L-phenylalanine methyl ester with a L-aspartic acid derivative in which the amino group is pro ⁇ tected from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing acylation of D,L-phenylalanine methyl ester with a L-aspartic acid derivative in which the amino group is protected from the remainder of the reaction mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the hydrolysis of an amide or an ester of an amino carboxylic acid to provide the corresponding free acid or a salt thereof from the remainder of the reaction mixture when the hydrolysis is conducted at such conditions that the product formed or a part thereof precipitates from the reac ⁇ tion mixture.
  • the invention relates to a method of separating an immobilized enzyme used for catalyzing the conversion of fumaric acid or a salt thereof to malic acid or a salt thereof from the solid product obtained when the reaction is conducted at such con- ditions that the product formed or a part thereof precipi ⁇ tates from the reaction mixture.
  • the separation method according to the present invention is particularly useful when a heterogeneous cata- lyst, e.g. a solid, particulate, immobilized enzyme, is to be separated from a reaction mixture which further contains at least one other particulate, solid component.
  • This other par ⁇ ticulate, solid component can either be a product synthesized under the influence of the catalyst or it can be unreacted starting material e.g. a starting material added in excess.
  • the word product when not further specified can mean either the desired product or a by-product resulting from a reaction.
  • the catalyst When the catalyst is the only solid component present in the reaction mixture at the beginning of the reac ⁇ tion and the product is sparingly soluble in the liquid ⁇ art of the reaction mixture the catalyst can be separated from the reaction mixture by giving the solid product particles an apparent particle size which is outside the apparent particle size range of the solid catalyst particles whereupon the re ⁇ action mixture is filtered or centrifuged using a filter or a centrifuge which will retain the component having the larger particles and let the remainder of the reaction mixture pass through.
  • the liquid part of the reaction mixture is designated "the reaction liquid” or just "the liquid”.
  • the reaction liquid thus comprises the solvent (or solvent mixture) in which the reaction is conducted and the dissolved part of starting materials and products be they solids or liquids.
  • the separation of the catalyst from the remainder of the re ⁇ action mixture can be performed in a continuous way by leading the filtrate from the filter which retains the cata ⁇ lyst only to a filter which retains the solid product syn ⁇ thesized and recirculating the filtrate from this filter to the catalyst. In this way the equilibrium of the reaction is influenced towards a higher yield.
  • One or more starting materials may be sparingly soluble in the solvent in which the reaction is performed. In this case the starting material(s) may be present in solid form in the reaction mixture and the reaction liquid will then be saturated with respect to the pertinent component(s) .
  • the problem to be solved by the present invention during the working up is to separate the catalyst from the reaction liquid containing solid, unreacted starting material. If the product is also sparingly soluble in the reaction liquid the product and the unreacted starting material will have to be separated from each other after the catalyst has been separated from the remainder of the reac ⁇ tion mixture.
  • the true dimension of particles like crystals can be determined e.g. by using a microscope equipped with a suitable scale. Particles come in many different shapes. Thus crystals can e.g. be needle-like, plate-like or cubic.
  • the important feature in the present context is not the true dimension of the particles but rather the apparent dimension e.g. stated as the apparent diameter.
  • the designation "apparent dimension” or "apparent dia- meter” is used to reflect how a particle behaves on a sieve or a filter.
  • the apparent diameter of a particle cor ⁇ responds to the diameter of a hole or a pore which in prac ⁇ tical use will just allow the particle to pass through it.
  • the particle size of the catalyst is reduced as much as the separation procedure allows. This helps to ensure a high activity of the catalyst and helps to eliminate diffusion problems.
  • the solid catalyst to be used according to the present method may exist in the form of a particulate immobi ⁇ lized enzyme preparation and may have a density higher or lower than that of the reaction liquid. In this preparation, the enzyme may be adsorbed, absorbed, covalently bound, entrapped or bound by ionic forces.
  • Methods for immobilizing enzymes are known in the art. The known art also provides methods for preparing particles for carrying immobilized catalysts e.g. enzymes and for isolating various fractions of particulate solids according to their particle size distribu ⁇ tion.
  • the specific catalyst to be used in each case depends on the process to be conducted. The process of this invention is generally carried out in water. Optionally, organic solvents can be added.
  • Organic solvents are preferably selected among water- miscible solvents such as methanol, ethanol, 1-propanol, 2- propanol, 1-butanol, 1,4-butanediol, acetone, acetonitrile, N,N-dimethylformamide and dimethylsulfoxide.
  • water- miscible solvents such as methanol, ethanol, 1-propanol, 2- propanol, 1-butanol, 1,4-butanediol, acetone, acetonitrile, N,N-dimethylformamide and dimethylsulfoxide.
  • the temperature is one of the parameters which influences the size of the particles when a solid product is formed. This can be because the growth rate of the crystals depends on the temperature or in some cases because different crystal modifications occur at different temperatures.
  • the freezing point of the reaction liquid forms the absolute lower temperature limit for carrying out the method of the present invention. If the catalyst used is an immobilized enzyme the absolute upper temperature limit for carrying out the method will usually depend on the enzyme.
  • Examples of specific areas within which the present invention leads to essential improvements are: 1) Preparation of semisynthetic penicillins and cephalosporins, 2) Hydrolysis of amides and esters and 3) Synthesis of pep ⁇ tides.
  • Examples of /3-lactam antibiotics penicillins and cephalosporins which can be prepared with advantage using the method of the present invention are ampicillin, amoxi- cillin, ticarcillin, cefaclor, cefatrizine, cefaparol, cephalexin, cefadroxil, cephaloglycin and cephalothin.
  • semisynthetic /3-lactams are prepared in industry by chemical methods.
  • Penicillins for example, are prepared by reacting 6-APA, usually having its carboxyl group protected, with an activated side chain derivative, followed by removal of the protecting groups by hydrolysis.
  • ampicillin can be prepared by reacting 6-APA, having a suit ⁇ ably protected carboxylic acid group, with D-phenylglycyl chloride, followed by hydrolytic removal of the group which protects the carboxylic acid group.
  • These reactions typically involve costly steps such as the use of temperatures below 0°C (in certain cases even below -25°C) , silylation reagents and organic solvents like methylene chloride, which must be handled with care since they are injurious to health and harmful to the environment.
  • Enzymatic production of semisyntetic /3-lactam antibiotics by acylation of a / 3-lactam nucleus with a deriva ⁇ tive (such as a lower alkyl ester) of D-phenylglycine or D-4- hydroxyphenylglycine is known e.g. from DE patent application No. 2,163,792, AT patent No. 243,986, NL patent application No. 70-09138, DE patent application No. 2,621,618 and EP patent application publication No. 339,751.
  • Processes de ⁇ scribed in the prior art have typically been conducted at concentrations below 300 mM of the D-phenylglycine derivative and below 25 mM of the /3-lactam nucleus. This rather low concentration of the starting materials is a potential drawback of these known methods for enzymatic production of semisynthetic /3-lactam antibiotics
  • the yields re ⁇ ported are low, typically less than 85%, and a process for recycling the unreacted / 3-lactam nucleus is ret..red, which leads to more and costly unit operations.
  • the need then arises to separate the catalyst from the reaction mixture containing solid products and/or unreacted starting materials, before the remainder of the reaction mixture is further worked up as the working up may involve conditions harmful to the enzyme activity, for example, dissolution of products and unreacted starting materials at a low pH value (e.g. at a pH value of 50.5 - 2.0) .
  • the acylating agent used for introducing the sidechain in a /3-lactam antibiotic nucleus i.e. for introduc ⁇ ing the acyl group in the 6-amino group of the penicillins or in the 7-amino group of the cephalosporins can be the corre-
  • the methyl ester, the ethyl ester, and the amide are preferred.
  • the derivative may be used in the free form or in the form of a salt, for
  • the enzyme to be used may be any enzyme catalyz ⁇ ing the reaction in question. Such enzymes are usually termed penicillin amidases, penicillin acylases, or ampicillin hydrolases. A number of microbial enzymes known to have this
  • 20 activity are derived from, for example, Acetobacter. Xantho- monas, Mvcoplana. Protaminobacter, Aero onas DE patent appli ⁇ cation No. 2,163,792) Pseudo onas (AT patent No. 243,986), Flavobacterium (NL patent application No. 70-09138) , Aphano- cladium, Cephalosporium (DE patent application No.
  • Acetobacter pasteurianus DE patent application No. 2,163,792 A
  • Acetobacter turbidans Takahashi et al. , Biochem.J. 137 (1974), 497 - 503
  • Pseudomonas melanogenum Kim & Byun, Biochim.Biophys. Acta, 1040 (1990) , 12 - 18)
  • Xanthomonas citrii EP patent application publication No.
  • the catalyst can be reused, optionally after having gone through a washing procedure. Products and optio ⁇ nal unreacted starting material can be separated and worked up separately or recycled respectively.
  • ZAPM N-benzyloxycarbonyl-L-aspartyl-L-phenylalanine methyl ester
  • one of the critical steps involves an enzyme cata ⁇ lyzed coupling of an aspartic acid derivative and phenyl- alanine methyl ester hydrochloride (for example coupling N- benzyloxycarbonyl-L-aspartic acid and L-phenylalanine methyl ester hydrochloride to form ZAPM.
  • the ZAPM forms a very sparingly soluble addition compound with L-phenylalanine methyl ester (or D-phenylalanine methyl ester, if present) and therefore precipitates during the synthesis.
  • the equili ⁇ brium of the reaction is hereby shifted towards condensation.
  • a semi-purified, soluble enzyme preparation e.g. thermolysin
  • the reaction product is dissolved and the enzyme is precipitated by addition of an organic solvent (for example acetone) and removed, for example, by filtration.
  • an organic solvent for example acetone
  • Immobilized penicillin G acylase from E. coli 250 g, Eupergit ® -PcA, obtained from Rohm Pharma
  • E. coli 250 g, Eupergit ® -PcA, obtained from Rohm Pharma
  • the material retained on the 180 ⁇ m screen was used as the enzyme catalyst in the examples 2-5 given below.
  • the activity of the catalyst was 115 penicil ⁇ lin G acylase Units (U) per g of moist catalyst.
  • D-phenylglycine methyl ester in the following designated D-PGM
  • 6-aminopenicillanic acid in the fol ⁇ lowing designated 6-APA
  • the temperature of the suspension was brought to 35 °C and 10.0 g of moist immobilized enzyme (according to Example 1) was added, the total volume being 100 ml.
  • the reaction was allowed to proceed with efficient stirring at 35 °C, the pH value being kept at 6.0 by titration with 2 M H 2 S0 4 .
  • D-phenylglycine in the following designated D-PG
  • D-PG D-phenylglycine
  • the ampicillin concentration reached a maximum of 77 mM, corre ⁇ sponding to 85% conversion of the 6-APA.
  • the contents of the reaction vessel were transferred to a filter unit having a 100 ⁇ m pore size screen as the bottom and a rotating propeller placed immediately above the screen.
  • the immobilized enzyme was retained by the screen while the remaining part of the slurry passed through.
  • the precipitate in this filtrate consisted of D-phenylglycine crystals con ⁇ taining some ampicillin and the liquid contained i.a. dis- solved product and unreacted starting materials.
  • the ampicil ⁇ lin crystals formed had a particle size of less than 50 ⁇ m.
  • the filtrate i.e. the slurry comprising the crystals and the reaction liquid
  • the clear centrifugate was used to wash off crystals remaining on the catalyst.
  • the catalyst was kept in suspension at all times during the separation. When no crystals could be seen in the catalyst fraction the tank was drained completely, leaving only the catalyst on the screen.
  • Eluent A 25 mM phosphate buffer, pH value 6.5.
  • Eluent B acetonitrile.
  • D-phenylglycine methyl ester, HCl-salt, (1.6526 g) and 7-aminodesacetoxycephalosporanic acid (7-ADCA) (0.4278 g) were dissolved in 50 mM phosphate buffer (pH value: 6.5) and thermostated to 35°C.
  • Enzyme catalyst according to Example 1 (2 g) was added and the volume of the reaction mix ⁇ ture was adjusted to 20 ml with buffer. The reaction was allowed to proceed under efficient mixing, keeping the pH value and temperature constant.
  • cephalexin was isolated and purified by known methods. More than 99% of the catalytic activity was retained in the catalyst after the separation step and the catalyst was thus suitable for reuse. A rinsing step may be introduced before the catalyst is reused.
  • the concentration of amoxicillin reached a maximum corresponding to 85% conversion and the reaction mixture contained, i.a. , crystals of amoxicillin, D- 4-hydroxyphenylglycine (in the following designated HPG) and unreacted HPGA.
  • HPG D- 4-hydroxyphenylglycine
  • the recirculation of the filtrate to the reaction vessel was stopped and instead the filtrate was led to a centrifuge. As described in the previous two examples the clear supernatant was used for washing off the last crystals from the catalyst.
  • amoxicil- lin was further purified by methods known in the art.
  • the catalyst used was suitable for reuse since more than 99% of its catalytic activity was retained.
  • the fil ⁇ trate from this separation comprised the precipitated HPG and the supernatant which contained, i.a. , salts and dissolved HPG. In total 96% of the HPG formed was found in the fil ⁇ trate.
  • the HPG was further purified by known methods.
  • the catalyst in the reaction vessel was washed with 50 mM phosphate buffer (pH value: 6.0) and was reused without a significant loss of catalytic activity (less than 1% of the total activity was lost during the synthesis and subsequent separation) .
  • thermolysin catalyst Preparation of a thermolysin catalyst.
  • Thermolysin (8 g, Sigma P-1512) was dissolved in 25 mM of phosphate buffer (pH value: 7) to approximately 50 mg protein per ml and approximately 3750 U (vide infra) per ml.
  • Cells from an E. coli fermentation e.g. A. Gebauer et al. - Bioprocess Engineering 2. (1987) 55-58
  • the thermo ⁇ lysin was added to the cells which were immobilized as described in W ⁇ mpelmann, M. et al. US patent No. 4,892,825 (to Novo Industri A/S) .
  • the material carrying the immobilized cells was extruded and dried to approximately 10% water con ⁇ tent. The resulting particles were milled and the milled material was sieved. The 75 - 150 ⁇ m particle size fraction was used as catalyst in the synthesis of N-benzyloxycarbonyl- L-aspartyl-L-phenylalanine methyl ester. The activity of the catalyst was approximately 3000 U per g. The activity was measured by the casein digestion method (1 unit (U) will hydrolyze casein to produce color equivalent to 1.0 ⁇ ole of tyrosine per minute at a pH value of 7.5 at 35°C (color by Folin-Ciocalteu reagent) ) .
  • N-benzyloxycarbonyl-L-aspartic acid (0.1 mole) and L-phenylalanine methyl ester hydrochloride (0.25 mole) was dissolved in water and adjusted to a pH value of 6.5 and a final volume of 350 ml.
  • the solution was thermostated at 40°C and catalyst prepared as described above (15 g) was added.
  • the catalyst was swelled in water before use, whereby the particle size increased to approximately 150-400 ⁇ m.
  • the reaction was allowed to proceed at 40"C keeping the pH value constant at 6.5 and maintaining an efficient low shear stirring.
  • the condesation product, N-benzyloxycarbonyl-L- aspartyl-L-phenylalanine methyl ester forms an addi- tion compound with unreacted L-phenylalanine methyl ester which has a very poor solubility in water. Accordingly, the product precipitated almost quantitatively as this addition compound gradually as it was formed.
  • the reaction mixture was cooled to approximately 5°C and trans- ferred to the separation unit described in Example 2.
  • the catalyst was separated from the product and the reaction liquid as described in Example 2.
  • the catalyst in the reac ⁇ tion vessel can be reused as more than 99% of the total cata ⁇ lytic activity was retained after the separation step.
  • ZAPM can be further processed to aspartame by methods known per se (removal of the N-protection group of the aspartic moiety, crystallization etc.).
  • E. coli having Penicillin G acylase activity was fermented according to Gebauer, A. et al. Bioprocess Engi ⁇ neering 2 (1987) 55-58. Immobilization was performed according to W ⁇ mpelmann, M. et al. US Patent No. 4,892,825 (to Novo Industri A/S) .
  • the substance containing the immo ⁇ bilized enzyme was extruded and dried until the residual water content was approximately 10 % (w/w) .
  • the dried mate ⁇ rial was milled and a fraction having a particle size distri ⁇ bution of 100-200 ⁇ m was obtained from the milled product by the use of appropriate sieves.
  • the enzyme activity in this fraction was found to be approximately 200 Penicillin G acylase Units/g. After swelling in water, the particle size distribution was approximately 200-500 ⁇ m.
  • the reaction mixture was poured on to a 100 ⁇ m pore screen, which retained the particles carrying the enzyme while the remaining part of the reaction mixture, still a slurry, passed through.
  • the slurry passing the screen was filtered on a sintered glass filter which retained the solid material and some of the mother liquor was used to wash the solid material remaining on the 100 ⁇ m screen in order to free the enzyme particles from any adhering fine slurry containing the synthesized product. Also the washings were filtered through the sintered glass filter.
  • the product collected on the glass filter was washed with butyl acetate (200 ml) and then suspended in a mixture of water (150 ml) and butyl acetate (150 ml) .
  • the pH value of the water phase was adjusted to 1.5 by addition of 3 M sul ⁇ furic acid and stirring was continued for 10 minutes.
  • the water phase was then separated from the butyl acetate phase and washed with further butyl acetate (2x20 ml) .
  • the volume of the water phase was reduced to 75 ml by evaporation, 2- propanol (75 ml) was added and the pH value was adjusted to 4.7 by addition of 4 M ammonium hydroxide.
  • the slurry ob ⁇ tained was cooled to 5 °C for 15 minutes, whereupon the solid material was collected on a sintered glass filter and washed with water/2-propanol (1:1, 25 ml).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Catalysts (AREA)
PCT/DK1993/000159 1992-05-14 1993-05-13 Separation method WO1993023164A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BR9306349A BR9306349A (pt) 1992-05-14 1993-05-13 Processo para separar um catalisador sólido particulado de uma mistura reacional
JP5519788A JPH07507959A (ja) 1992-05-14 1993-05-13 分離方法
SK1342-94A SK134294A3 (en) 1992-05-14 1993-05-13 Method of separation of particle solid catalyst
EP93909823A EP0640014A1 (de) 1992-05-14 1993-05-13 Trennungsmethode

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0641/92 1992-05-14
DK64192A DK64192D0 (da) 1992-05-14 1992-05-14 Separationsmetode

Publications (1)

Publication Number Publication Date
WO1993023164A1 true WO1993023164A1 (en) 1993-11-25

Family

ID=8095895

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1993/000159 WO1993023164A1 (en) 1992-05-14 1993-05-13 Separation method

Country Status (10)

Country Link
EP (1) EP0640014A1 (de)
JP (1) JPH07507959A (de)
CN (1) CN1081929A (de)
AU (1) AU4061393A (de)
BR (1) BR9306349A (de)
DK (1) DK64192D0 (de)
MX (1) MX9302724A (de)
SK (1) SK134294A3 (de)
TW (1) TW304886B (de)
WO (1) WO1993023164A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004732A1 (en) * 1996-07-26 1998-02-05 Bristol-Myers Squibb Company SYNTHESIS OF β-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
WO2003078059A1 (de) * 2002-03-15 2003-09-25 Basf Aktiengesellschaft Katalysator-precursor für die herstellung von maleinsäureanhydrid und verfahren zu dessen herstellung
WO2017186864A1 (en) * 2016-04-27 2017-11-02 Sandoz Ag Enzymatic process for the production of beta-lactam antibiotics in the presence of particulate inoculum

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Dialog Information Services, File 351, WPI 81-92, Dialog Accession No. 008561914, (PETR) VEB PETROCHEM SCHWEDT), "Fines Removal from Palladium-Active Carbon Catalyst - Using Sieve with Specified Mesh Width and Catalyst Vol. Flow"; & DD,A,283030, 901003, 9110. *
Dialog Information Services, File 351: WPI 81-92, Dialog Accession No. 007453169, (KYOWA HAKKO KOGYO KK), "Prodn. of Immobilised Cells - Involves Treating Cells with Polyamine and Dialdehyde"; & JP,A,63 036 785, 880217, 8813. *
Dialog Information Services, File 351: WPI, 81-92, Dialog Accession No. 004310425, (KONISHIROKU PHOTO KK), "Analytical Vessel for Immunoassay Use Contains Buffer liq. for Immune Reaction and Carrier for Immobilisation of Particular Components in Fluid Sample"; & JP,A,60 017 357, 850129, 8523. *
Dialog Information Services, File 351; WPI 81-92, Dialog Accession No. 007140942, (MITK) MITSUI TOATSU CHEM INC), "Recycling Catalyst Comprises Sepq., Catalyst Components as Solid from Reaction Soln. Contq. Components and Subjecting Sepd. Components to Oxidn. Treatment"; & JP,A,62 081 350, 870414, 8720. *
Dialog Information Services, File 5: Biosis, 68-90/May, Accession No. 6581148, Biosis Accession No. 86047699, TAKAMATSU S. et al.: "Recirculating Bioreactor-Separator System for Simultaneous Biotransformation and Recovery of Product Immobilized L Aspartate Beta-Decarboxylase Reactor System", Biotechnology Bioeng 32 (2) 1988, *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004732A1 (en) * 1996-07-26 1998-02-05 Bristol-Myers Squibb Company SYNTHESIS OF β-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
US5922907A (en) * 1996-07-26 1999-07-13 Bristol-Myers Squibb Co. Precursors of β-lactam antibacterials having soluble side chain esters
US6156534A (en) * 1996-07-26 2000-12-05 Bristol-Myers Squibb Company Synthesis of β-lactam antibacterials using soluble side chain esters and enzyme acylase
AU727543B2 (en) * 1996-07-26 2000-12-14 Bristol-Myers Squibb Company Synthesis of beta-lactam antibacterials using soluble side chain esters and enzyme acylase
WO2003078059A1 (de) * 2002-03-15 2003-09-25 Basf Aktiengesellschaft Katalysator-precursor für die herstellung von maleinsäureanhydrid und verfahren zu dessen herstellung
WO2017186864A1 (en) * 2016-04-27 2017-11-02 Sandoz Ag Enzymatic process for the production of beta-lactam antibiotics in the presence of particulate inoculum

Also Published As

Publication number Publication date
TW304886B (de) 1997-05-11
AU4061393A (en) 1993-12-13
BR9306349A (pt) 1998-06-30
DK64192D0 (da) 1992-05-14
CN1081929A (zh) 1994-02-16
MX9302724A (es) 1994-08-31
SK134294A3 (en) 1995-07-11
EP0640014A1 (de) 1995-03-01
JPH07507959A (ja) 1995-09-07

Similar Documents

Publication Publication Date Title
US5470717A (en) Method for the preparation of certain β-lactam antibiotics
CA2086250C (en) Process for preparation of beta-lactams
EP0771357B1 (de) Verfahren zur herstellung von beta-lactamen mit dauernd hochkonzentrierten reagenzien
EP0865443B1 (de) Verfahren zur herstellung eines anitibiotkums
EP0640014A1 (de) Trennungsmethode
WO1992012782A1 (en) Process for separation of two solid components
EP0730036B1 (de) Verfahren zur enzymatischen Synthese von beta-laktam Antibiotika in Anwesenheit von einem Enzyminhibitor
EP1416054B1 (de) Einfaches enzymatisches Verfahren zur Herstellung von Cefazolin
NL1007828C2 (nl) Complexen van beta-lactam antibiotica en 1-naftol.
NL1013402C2 (nl) Werkwijze voor de bereiding van een beta-lactam antibioticum.
NL1007827C2 (nl) Complexen van beta-lactam antibiotica.
EP0997199A1 (de) Verfahren zur Trennung von festen Verbindungen in Suspension
US20040053912A1 (en) Process for the preparation of a beta -lactam nucleus and the application thereof
EP0815256A1 (de) Verfahren zur herstellung von einem beta-lactam antibiotika

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1993909823

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 134294

Country of ref document: SK

ENP Entry into the national phase

Ref document number: 1994 335793

Country of ref document: US

Date of ref document: 19941110

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1993909823

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1993909823

Country of ref document: EP